yl23455永利官网

洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
医药数据查询

【ChiCTR1900026244】乳腺癌生存者自我管理應用程式的隨機對照試驗

基本信息
登记号

ChiCTR1900026244

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2019-09-28

临床申请受理号

/

靶点

/

适应症

乳腺癌

试验通俗题目

乳腺癌生存者自我管理應用程式的隨機對照試驗

试验专业题目

Breast Cancer App protocol: a randomized controlled trial to evaluate a self-management app for breast cancer survivors

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

1) to examine whether there is the difference in the health literacy, problem solving skills, readiness of change, self-efficacy, self-management skill, and health-related quality of life between the intervention group and the control group; 2) to examine the usability of this self-management app versus a general health app.

试验分类
试验类型

随机平行对照

试验分期

探索性研究/预试验

随机化

SPSS (IBM SPSS Statistics Version 25) will be used to generate the random sequence for group allocation.

盲法

Not addressed

试验项目经费来源

Departmental research fund

试验范围

/

目标入组人数

244

实际入组人数

/

第一例入组时间

2020-01-01

试验终止时间

2021-06-30

是否属于一致性

/

入选标准

1) female; 2) breast cancer survivors; 3) Cancer stages I to III; 4) completion of primary treatment within one year or longer; 5) aged 18 to 65 years; 6) acceptable literacy level (e.g. able to read, and write Chinese); 7) agree for checking of usage log of mobile app; 8) able to provide informed consent.；

排除标准

1) BCS diagnosed with severe mental illnesses; 2) Diagnosis of another cancer type rather than breast cancer; 3) has already participated in other clinical trial; 4) has been used other self-management app to manage the breast cancer.；

研究者信息
研究负责人姓名
试验机构

香港理工大學康復科學系

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址

最新临床资讯